Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
Top Cited Papers
Open Access
- 13 July 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 103 (4), 469-474
- https://doi.org/10.1038/sj.bjc.6605779
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trialsBritish Journal of Cancer, 2009
- Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 StudyBritish Journal of Cancer, 2009
- Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first‐line palliative chemotherapyCancer, 2009
- Epidemiology of biliary tract cancers: an updateAnnals of Oncology, 2008
- Phase-II Study of Gemcitabine and Cisplatin in Patients with Metastatic Biliary and Gallbladder CancerDigestive Diseases and Sciences, 2007
- Gemcitabine in advanced biliary tract cancersCritical Reviews in Oncology/Hematology, 2007
- Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trialsBritish Journal of Cancer, 2007
- Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997–2002Cancer Causes & Control, 2007
- International Comparisons of Cumulative Risk of Gallbladder Cancer and other Biliary Tract Cancer, from Cancer Incidence in Five Continents Vol. VIIIJapanese Journal of Clinical Oncology, 2007
- Differential Cell Cycle–Regulatory Protein Expression in Biliary Tract Adenocarcinoma: Correlation With Anatomic Site, Pathologic Variables, and Clinical OutcomeJournal of Clinical Oncology, 2006